Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subgroup analyses in randomized clinical trials: statistical and regulatory issues.

Jean-Marie Grouin1, Maylis Coste, John Lewis

  • 1University of Rouen, Mont Saint Aignan, France. jean-marie.grouin@univ-rouen.fr

Journal of Biopharmaceutical Statistics
|August 5, 2005
PubMed
Summary

This article clarifies the appropriate use and interpretation of subgroup analyses in clinical trials for regulatory submissions. It addresses common questions about validity and provides guidance for researchers and regulators.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke-ACTISAVE: A Prospective, Randomized, Double-Blind Study.

Stroke·2026
Same author

Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.

Rheumatology and therapy·2026
Same author

Effects of Light-Induced Electromagnetic Fields on Human Cancer Cells <i>in Vitro</i>.

Bioelectricity·2026
Same author

Electrolocation without an electric image.

Physical biology·2025
Same author

Blood flow restriction during high load bench press does not increase bar velocity or cause physiological changes in non-occluded agonist muscles.

Clinical physiology and functional imaging·2025
Same author

Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate Cancer.

Clinical genitourinary cancer·2024

Area of Science:

  • Clinical Trials Methodology
  • Regulatory Science
  • Biostatistics

Background:

  • Subgroup analyses are frequently used in clinical trials but their validity is often questioned.
  • Regulatory bodies like CPMP have issued guidance on subgroup analyses, particularly concerning baseline covariates and multiplicity.
  • Despite attention, a clear understanding of when and how to conduct and interpret subgroup analyses remains a challenge.

Purpose of the Study:

  • To provide guidance on the appropriate application of subgroup analyses in clinical trials.
  • To clarify when subgroup analyses can and should be performed.
  • To discuss the interpretation of subgroup analyses and their validity for regulatory claims.

Main Methods:

  • Review of existing regulatory guidelines (CPMP Points to Consider).

Related Experiment Videos

  • Discussion of the statistical principles underlying subgroup analysis.
  • Analysis of the validity of common regulatory claims derived from subgroup analyses.

    • Main Results:

    • The article outlines conditions under which subgroup analyses are valid and informative.
    • It differentiates between planned and post-hoc subgroup analyses.
    • Guidance is provided on interpreting results and avoiding common pitfalls in regulatory claims.

    Conclusions:

    • Subgroup analyses require careful planning and justification to be valid for regulatory purposes.
    • Proper interpretation is crucial to avoid overstating findings or making unsupported claims.
    • Adherence to methodological and statistical best practices enhances the utility of subgroup analyses in drug development.